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Representational difference analysis of cDNA of genes expressed in
embryonic kidney. Representational difference analysis of eDNA (eDNA-
RDA) is a PCR-based differential cloning method. It involves hybridiza-
tion of two populations of eDNA with selective amplification of differen-
tially expressed genes. To isolate the differentially expressed genes during
renal development, mRNAs from embryonic kidneys at day 13 (E13) and
postnatal kidneys from three-week-old (P3) mice were extracted, and
double stranded cDNAs prepared. Double stranded cDNAs were digested
with DpnII, adaptor-ligated, and amplified by PCR, using adaptor primer
to generate "representative amplicons." These reflect the "representa-
tion" of most of the eDNA population. The term "amplicons" denotes
amplified PCR product. Among the two populations of eDNA, E13 kidney
eDNA was used as a "tester," containing target genes, and P3 kidney
eDNA as a "driver," driving the process of subtraction, following which,
they were subjected to cDNA-RDA under low stringency conditions.
During the first round of cDNA-RDA, embryonic globin genes were
isolated. To competitively eliminate these genes, plasmid DNAs of globin
genes were supplemented into driver, and subjected to the second round
of cDNA-RDA. This resulted in the isolation of four eDNA clones: H19
gene, mesoderm-specific eDNA, COL2A1 gene, and a novel eDNA. By
Northern blot analyses, the H19 gene and rnesoderm-specific eDNA
exhibited a high degree of developmental regulation, that is, they were
abundantly expressed in E13 kidney, and their expression was barely
detectable in P3 kidney. The differential developmental regulation of
mesoderm-specific eDNA was confirmed by tissue in situ hybridization
experiments. The COL2A1 and novel eDNA were rare transcripts in the
embryonic kidney. However, Southern blot analyses of representations
indicated their up-regulated expressions in E13 kidneys. The novel gene
was differentially expressed in 13-day embryonic lung, and Northern blot
analysis revealed an --10 Kb transcript. These results indicate that
cDNA-RDA is a sensitive technique to identi rare transcripts with
differential expression, and since there is a minimal chance to isolate false
positive clones, cDNA-RDA may serve as a powerful tool for delineating
up- or down-regulation of the genes involved in various pathological or
physiological states of the kidney.
Analysis of differentially expressed mRNAs in various physio-
logical or pathological states, including embryonic development
and oncogenesis, has been one of the major thrusts in molecular
biology and medicine in recent years. Until recently, subtractive
[1, 2] and differential [3] hybridization have been employed to
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identify differentially regulated genes. However, these methods
are time consuming, and moreover, they require a large amount of
mRNA to generate eDNA for the subtraction processes [4]. Some
of these problems have been overcome by another method known
as differential display-PCR (DD-PCR) [4, 51,which involves three
steps: (1) random and oligo (dT)-primed amplification of a
fraction of total mRNA from two populations by polymerase
chain reaction (PCR); (2) side-by-side comparison of the ampli-
fied PCR products in a nucleotide sequencing gel; and (3)
isolation of bands, which are differentially expressed. However,
usage of relatively short 5' random primers and non-specific
oligo-(dT) primer in DD-PCR quite often results in the isolation
of false positive clones, which fail to exhibit differential expression
by Northern blot analyses. A second PCR-based differential
cloning method known as "representational difference analysis of
eDNA" (cDNA-RDA) has been described [6]. RDA involves
hybridization coupled with PCR amplification, originally devel-
oped for the identification of the differences between complex
genomic DNAs [7], and can be successfully employed for the
analyses of cDNAs as well [61. For the cDNA-RDA, double
stranded cDNAs from two different populations are digested with
four-cutting ( GATC) enzymes (DpnII), ligated with adaptor,
and PCR-amplified by using a relatively long 24-mer adaptor
primer to generate representations. The target genes which are
differentially expressed in tester representation are enriched by
two processes: (1) hybridization of adaptor-ligated tester with
excess amount of adaptor-digested driver representation; and
(2) PCR amplification of hybridization mix by adaptor primer.
The cDNA-RDA has several advantages over DD-PCR: (1)
isolation of very few false positive clones, because a specific
24-mer adaptor primer for amplification is used; (2) sensitivity
to identify the differentially expressed genes by altering the
hybridization stringency, that is, driver:tester ratio; (3) final
difference products of target genes can he easily analyzed by
ethidium-bromide agarose gel electrophoresis; (4) only differ-
entially expressed cDNAs are amplified during PCR; (5)
unwanted difference products can be competitively eliminated
during RDA; (6) rarely expressed mRNAs are detectable; and
(7) higher chances to obtain eDNAs with an open reading
frame [6]. Taken these advantages into consideration, eDNA-
RDA was used, with certain modifications, to identify the
differentially expressed genes during mouse metanephric de-
velopment.
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Fig. I. Flow-chart diagram depicting various
steps of representational difference analysis (RDA)
of eDNA. The superscript Roman letters
indicate the number of cycles for hybridization
and amplification of cDNA-RDA. For instance,
in the first cycle, Tester' is ligated to J'-linker,
hybridized with driver with a ratio of 1:100' to
generate DPi', difference product. The fourth
cycle to generate DP4 may be necessary if the
agarose gel electrophoretogram shows a heavy
smear of high background DNA.
Methods
Animals
ICR mice (Harlan Sprague Dawley, Inc., Indianapolis, IN,
USA) were used. Paired male:female mating was carried out, and
the appearance of vaginal plug was designated as day-0 of the fetal
gestation. Fetuses were removed at days 13 (E13) and 17 (E17) of
the gestation, and embryonic kidneys, lungs, brains, and livers
were harvested, snap-frozen in liquid nitrogen and stored at
—70°C. In addition, various organs from newborn and three-
week-old mice were dissected, snap-frozen and subjected to RNA
extraction.
Total RNA and mRNA isolation
Total RNA from embryonic (E13 and E17), newborn and
three-week-old (P3) mice kidneys were isolated by the guani-
dinium isothiocyanate-CsC1 centrifugation method [8]. For the
isolation of E13 embryonic RNA, —1000 kidneys were used. Total
RNAs were also extracted from various organs, such as brain, lung
and liver, at different embryonic developmental stages (E13, E17),
and newborn and three-week-old mice. Poly (A) RNAs were
isolated by FastTrack 2.0 Kit (Invitrogen, San Diego, CA, USA)
from —1 to 2 mg of total RNAs extracted from E13 and P3
kidneys of mice.
Representational difference analysis of cDNA (cDNA-RDA) and
oligonucleotides
cDNA-RDA was carried out by the method of Hubank and
Schatz [6] with certain modifications. The major steps included:
(1) generation of representations, (2) hybridization and selective
PCR amplification, and (3) cloning and sequencing of "difference
products." These steps are depicted in the accompanying flow
chart (Fig. 1). Various deoxyoligonucleotides (ODNs) synthesized
in Northwestern University Biotechnology Facility were as fol-
lows:
Dissociation of R-Bgl-1 2, 3' end filling in reaction, and PCR amplification by R-Bgl-2j
'1iester, DPi", DP2", DP3"I Drivj
IDpnh1 digestion DpnII digestion
'I.
____
Ligate 12/24 (J', N", J", N")-Bgl Linkersj No ligation
Heat denaturation and hybridization of tester:driver
at ratio of 1:100', 1: 4.00", 1:80,000", 1:8OO,OOO''
Tester:Driver hybridj ITester:Tester hybrid Driver:Driver hybrid
I, I I
Dissociation of 1 2-mer (J', N", J", N")-Bgl-l 2, filling in reaction
and PCR amplification by (J', N", J", N")-BgI-24
1
Linear amplification
s5DNA digested with
Mung Bean Nuclease
Exponential amplification No amplification
I
d5DNA insusceptible to
Mung Bean Nuclease digestion
I Post-digest PCR amplification by (J', N", J", N")-Bgl-24
I
Difference product (DPi', DP2", DP3", DP4")I
Electrophoretic Analyses
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R-Bgl-24 5'—ACCACTCTCCAGCCTCTCACCGCA-3'
III II
R-Bgl-12 3'-AGTGGCGTCTAG--5'
J-Bgl-24 5'-ACCGACGTCGACTATCCATGAACA-3'
I II
J-Bgl-12 3'-GTACTTGTCTAG-5'
N-Bgl---24 5'-AGGCAACTGTGCTATCCGAGGGAA-3'
II I II I
N-Bgl-12 3'-GCTCCCTTCTAG-5'
The sequences of these ODNs and their abbreviations, such as
R-Bgl-24, have been previously described [6, 7], and they were
used either as primers or adaptors for hybridization and amplifi-
cation during cDNA-RDA. The modifications were made mainly
in the tester:driver ratio used at various steps of cDNA:RDA to
increase the detection of rare transcripts (vide infra).
Generation of representative amplicons
First strand eDNA synthesis was carried out by using Moloney
murine leukemia virus reverse transcriptase (MMLV-RT,
RNaseH; CLONTECH, Palo Alto, CA, USA) from 5 jig mRNA
of E13 and P3 mouse kidneys. Second strand synthesis was
performed by using RNaseH-DNA polymerase reaction [9]. Dou-
ble-stranded eDNA (2 jig) was digested with DpnII (175 GATC)
(New England Biolabs, Beverly, MA, USA), phenol-chloroform
extracted, ethanol-precipitated, and resuspended in 20 jil of TE
(10 mtvi Tris and 1 mivi EDTA, pH 8.0) buffer. Twenty microliters
of DpnII-digested cDNA was added to the ligation mixture
containing 8 jil of R-Bgl-24 (1 mg/mi), 4 jsl of R-Bgl-12 (1 mg/ml),
6 j.tl of 10 x ligation buffer (Boehringer Mannheim, Indianapolis,
IN, USA), and 19 jsl of water. Annealing was carried out at 50°C
for one minute, followed by cooling down to 10°C for one hour in
a PCR Thermal Cycler (Perkin-Elmer, Norwalk, CT, USA).
R-adaptor (R-Bgl-12 + R-Bgl-24) ligation was initiated by adding
3 jil of T4 DNA ligase (400 U/jiI; Boehringer Mannheim), and the
mixture incubated at 16°C for overnight. The ligation mixture was
diluted to 200 jil by adding 140 jil of TE. Following which, PCR
mixture was prepared in four separate Eppendorf tubes, each
containing 20 jsl of PCR 10 X buffer (100 mivi Tris-HCI, pH 8.3,
15 mM MgCI2, 500 mrvi KCI, 0.01% gelatin; Perkin-Elmer, Nor-
walk, CT, USA), 24 jil of nucleotide mix (2.5 mrvi dNTP each), 2
jil of R-Bgl-24, and 2 jil of diluted ligation mixture. The 12-mer
primer (R-Bgl-12) was dissociated from R-adaptor-ligated dou-
ble-stranded eDNA by heating at 72°C for three minutes, and 3'
end filling-in reaction was catalyzed by addition of 5 U of Taq
polymerase (Perkin Elmer) at 72°C for five minutes. Twenty
thermal cycles, 95°C for one minute and 72°C for three minutes,
were carried out. The PCR products of four tubes were combined,
phenol-chloroform extracted, ethanol precipitated, and sus-
pended in 100 jil of TE to yield R (representative)-amplicon
(amplified PCR product) with a DNA concentration of —0.5
mglml. Three hundred micrograms of P3 kidney, and 100 jig of
E13 kidney R-amplicons were prepared. The R-amplicon pre-
pared from E13 kidney was used as a tester, while that from P3
kidney as a driver. R-adaptors were removed from P3 kidney
R-amplicon by digesting with DpnII, phenol-chloroform ex-
tracted, ethanol precipitated, suspended in TE to yield a concen-
tration of 0.5 mg/ml. This was defined as the cut driver, and was
used for subtraction. To remove the digested R-adaptors, 20 jig of
DpnJI-digested E13 kidney R-amplicon was gel-purified by
QIAEX II (Qiagen, Chatsworth, CA, USA), and 2 jig of purified
amplicon was ligated to J-Bgl-24/12 adaptors as described above.
This was the J-ligated tester.
Hybridization and selective amplification
For the first subtractive hybridization, 0.4 jig (40 jil) J-ligated
tester was mixed with 40 jig (80 jil) of cut driver (1:100 ratio). The
mixture was phenol-chloroform extracted, ethanol precipitated,
and resuspended in 4 jil of 3 x EE buffer (30 mivi EPPS
{N-[2-hydroxyethyl]-piperazine-N'-3-propane-sulfonic acid}, pH
8.0, 3 mivi EDTA). The sample (tester plus driver) was heated to
98°C for six minutes in a Thermal Cycler, and 1 jil of 5 M NaC1 was
added, and was allowed to anneal at 67°C for 20 hours. This
hybridization mixture was diluted with stepwise addition of 8 jil of
TE containing 5 mg/ml yeast tRNA, 25 jsl and 362 jil of TE, with
a resulting total volume of 400 jil. To generate and amplify the
first difference product (tester minus driver), PCR reaction mix-
ture was prepared as described above, utilizing 20 jil of diluted
hybridization mixture, but without J-Bgl-24 primer in four sepa-
rate Eppendorf tubes. J-Bgl-12 primer was dissociated from the
tester:tester and tester:driver hybrid DNAs by heating at 72°C for
five minutes, and 3' end filling-in reaction was carried out by
adding 5 U Taq polymerase at 72°C for five minutes. After
addition of 2 jsl of J-Bgl-24 (1 mg/mi), amplification was per-
formed for 10 thermal cycles, each for 95°C one minute, 70°C
three minutes. During this step, tester:tester hybrid underwent
exponential amplification, while tester:driver hybrid had a linear
amplification, and no amplication occurred for the driver:driver
DNA hybrids. The amplified products in the four tubes were
combined, phenol-chloroform extracted, isopropanol precipitated
and resuspended in 40 jil of 0.2 x TE. To eliminate the
single-stranded DNA products of tester:driver hybrid that under-
went linear amplification, 20 jil of amplified product was digested
with 20 U of Mung bean nuclease in I X digestion buffer (New
England Biolabs) at 30°C for 35 minutes. The reaction was
terminated by adding 160 jil of 50 mrvi Tris-HCI (pH 8.9), and
heating at 98°C for five minutes, and immediately cooled on ice.
For the final amplification, 20 jil of Mung bean nuclease-digested
product and 2 jil of J-Bgl-24 (1 mg/mi) were used in PCR mixture
as described above. After heating at 95°C for one minute, the
reaction mixture was brought to 80°C, and then 5 U of Taq
polymerase was added, and subjected to 18 amplification cycles,
each at 95°C for one minute and 70°C for three minutes. This
resulted in the First difference product (DPI) (Fig. 1). The DPi
was phenol-chloroform extracted, isopropanol precipitated, and
resuspended in TE to yield a final concentration of 0.5 mg/mI.
A Second difference product (DP2) (Fig. 1) was generated as
follows: i-adaptors were digested with DpnlI, and were replaced
by N-adaptors (N-Bgl-12 and N-Bgl-24), and hybridization and
amplification were repeated under the conditions described
above, except annealing and extension temperatures were raised
to 72°C, and tester:driver ratio was changed to 1:400, that is, 100
ng of N-ligated DPI and 40 jig of the cut driver. To generate a
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Third difference product (DP3), N-adaptor of DP2 was replaced
by J-adaptor, the tester:driver ratio was changed to 1:80,000, that
is, 0.5 ng of J-ligated DP3 and 40 jig of the cut driver, and the final
(post-Mung bean nuelease digest) amplification was performed
for 22 thermal cycles of 95°C for one minute and 70°C for three
minutes each.
Cloning and sequence analyses of difference products
R-amplicon of E13 kidney, DPi, DP2, and DP3 were digested
with DpnII, and analyzed by 2% agarose gel electrophoresis. For
subcloning, DNA bands of DP3 were gel-purified, and ligated into
BamHI-digested pBluescript KS(+) (Stratagene, La Jolla, CA,
USA). In addition, whole population of DNAs, present in the DP3
solution, were randomly ligated into the plasmid vector following
a DpnII digestion. Double stranded plasmid DNAs were prepared
and sequenced by Sanger's dideoxy chain termination method
[101, using Sequenase version 2.0 kit (United States Biochemical,
Cleveland, OH, USA). Homology search was performed by the
BLAST program via the NCBI on-line seMce.
Northern blot analyses and Southern blot analyses of representative
amplicons
For Northern blot analysis, 30 jig of total RNAs, extracted from
E13, E17, newborn and P3 mouse kidneys, were glyoxalated,
subjected to 1% agarose gel electrophoresis, and capillary-trans-
ferred to nylon membranes (Pall Biosupport, Glen Cove, NY,
USA). The transferred RNAs were hybridized with [a-32PIdCTP-
random-radiolabeled cDNA clones derived from DP3. Mouse
-actin (GenBank accession #M62174; American Type Culture
Collection, Rockville, MD, USA) was used as a control. The nylon
filters were then washed at high stringency conditions with 0.1 x
SSC and 0.1% SDS at 60°C, and autoradiograms were prepared.
For Southern blot analyses, DpnII-digested R-amplicons (20 jig)
of E13 and P3 mouse kidneys were subjected to 2% agarose gel
electrophoresis. Gels were denatured with 1.5 M NaCI+ 0.5 N
NaOH, neutralized with 0.5 M Tris-HC1 (pH 7.4) + 1.5 M NaCI,
and DNAs transferred to nylon membranes. Finally, the trans-
ferred DNAs were hybridized with [a-32P]dCTP-radiolabeled
DP3 clones, and washed at high stringency conditions as described
above, and autoradiograms were prepared.
Expression studies by in situ hybridization
These experiments were performed to validate the differential
regulation of mesoderm-specific cDNA during metanephric de-
velopment, and E13 and P3 mouse kidneys were utilized. They
were fixed in 4% paraformaldehyde in RNase free PBS, pH 7.0,
for 12 hours at 4°C. Tissues were dehydrated in a graded series of
ethanol and embedded in paraffin. Three-micrometer-thick sec-
tions were prepared and mounted on HCI-treated and Vecta-
bond-coated (Vector Laboratories Inc., Burlingame, CA, USA)
glass slides. The sections were deparaffinized, hydrated, depro-
teinated by proteinase K, treated with triethanolamine-acctic
anhydride, and rehydrated. The sections were prehybridized in
the presence of formamide, dextran sulfate and Denhardt's
solution at 50°C for four hours, and hybridized with mesoderm-
specific cDNA riboprobes at 50°C overnight. The RNA probes
were prepared by using riboprobe in vitro transcription system
(Promega Biotec, Madison, WI, USA). Briefly, the pBluescript KS
(+) phagemid, containing mesoderm-specific cDNA insert (clone
#7), was linearized by restriction enzyme digestion. Radiolabeled
antisense and sense riboprobes were synthesized by incorporating
[a-33P]dUTP (Amersham Corp., Arlington Heights, IL, USA),
using T7 and T3 RNA polymerase. The newly synthesized ribo-
probes were subjected to limited alkaline hydrolysis to yield
polynucleotide fragments with size range of 100 to 150 bp, which
were purified by ethanol precipitation and used for hybridization.
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Fig. 2. A. Agarose gel electrophoretogram of
difference products obtained from 13-day
emb,yonic kidney representative amplicon (R-
amplicon) subtracted by three-week-old mouse
kidney. mRNAs were obtained from kidneys of
13-day fetus and three-week-old mouse, and
subjected to cDNA-RDA under low stringency
conditions. Difference products (DP) were
digested with DpnII and analyzed by 2%
agarose gel electrophoresis. R-Amplicon of 13-
day embryonic kidney, first, second, and third
difference products (DPI, DP2, and DP3) are
shown. Three distinct bands are visualized in
DP3. Clone #1(331 bp) Clone #3 (183 bp) are
identified as -globin, and Clone #2 (257 bp) as
Clone #4
€-globin genes of the mouse. B. Competitive
elimination of embryonic globin genes by
plasmid supplementation. Plasmid DNAS of
mouse embryonic globin genes were
supplemented into the R-amplicon of three-
week-old mouse kidney, and used as a driver.
cDNA-RDA was repeated using 13-day kidney
R-amplicon and plasmid-supplemented three
weeks-old mouse kidney R-amplicon. A single
band is visualized in DP3, and its sequence
analysis indicated that it is a fragment of mouse
H19 gene (Clone #4, 258 bp).
1 . - - .. . . . . - gatcgacaaatacctggaagacaaggcccctttccctcca 40 Clone#6
Ill
GGCAGTccctt 4 5 J:J5JQ43..
41 agc ttccagtacctgataacgatgaaatatggaagcaaagacgaaaacaa 90 Clone* 6
III
255 AGcAGcMGnGcTGnGMG&?GJ,JcSrGGflGcAMGMtfl . 206 1151043
91 cagtctgaaatatctgcagcagtagagcgtgctcgtaaacgccgtgagga 140 Clone#6
.. ;:$:::_i.GA 156 fl51043
141 ggaagagcgaaggatggaggaacagaggaaggcagcgtgcgcagagaaat 190 Clone*6
II 11111111111 II H
155 GGAAGAM*A TGGAAGAACMSOGMXMtt?flTGcGGAGAM%e 106 1151043
191 tgaagcagctggatgagaagctcgggatc 219 Clone*6
11111
105 TaZS 56 1151043
1 DRQIPGRQGPFPSKLPVP .DNDEIWKQRRKQ .QSEIS 35 Clone#6
liii
401 TEPG?PAPKPfl,PPGDYPDRGGP .PCKPPAflDtflWRQRRZQS$SEXS 449 IIAT2
36 AAVERARKRREEEERRMEEQRAAChEKLKQLDEXLGI 73 Clone# 6
III 1:1111 F 111:1: : tIll- 1111:1
450 LAVZRARERflEEERR*QEERRAACAZKLLPERRGhPD1cBLKA?AAP 499 13.-Vfl
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Fig. 3. A. Sequence alignment of clone #6 and EST (expression sequence tag) clone, yp84dlO.sl Homo sapiens eDNA clone 194131 3' similar to SP:S3 76 71
BAT2 protein (accession #H51043). BLAST search of EST division of the non-redundant GenBank+EMBL+DDBJ revealed that clone #6 has
sequence similarity with EST clone (accession #H51043). Nucleotide sequences of these two clones are aligned by the gap program (GCG package),
and they show 84% similarity. B. Sequence alignment of the translated product of clone #6 (frame + 1) and human BAT2 protein. BLASTX search of
the non-redundant GenBank CDS translations + PDB +SwissProt +PIR revealed that deduced amino acid sequence of clone #6 (frame + 1) had 70.8%
identity with human BAT-2 protein. The amino acid sequences are also aligned by the gap program (GCG package).
Table 1. Differentially expressed genes in 13-day mouse embryonic kidney, identified by representation difference analysis of eDNA
Clone name Length Gene name
GenBank accession #
(location) References
Clone #1 331 bp mouse €-globin M26897 (—13 —318) Wilkinson, 1987 [11}
Clone #2 183 bp mouse -globin M26898 (305—487) Wilkinson, 1987 [11J
Clone #3 257 bp mouse €-globin M26897 (315—572) Wilkinson, 1987 [111
Clone #4 259 bp mouse H19 gene X58196 (842—1100) Poirier, 1991 [121
Clone #5 198 hp mouse COL2A1 M63708 (783—970) Cheah, 1991 [131
Clone #6 219 bp ?
Clone #7 363_bp specific eDNA Dl6262 (738—1100) Sado, 1994 [141
Clone #1 starts 13 bp upstream of 5' end of reported mouse e-globin eDNA.
Alter hybridization with riboprobes (1 x io cpm/xl), the slides emulsion (Kodak, Rochester, NY, USA), and tissue autoradio-
were successively washed with SF solution (2 X SSC and 50% grams prepared after one week of exposure. The tissue sections
formamide), NTE buffer (0.5 M NaCI, 10 mvt Tris-HCI and 1 mt were stained with hcmatoxylin-phloxirie solution, cover slip
EDTA) and 0.1 x SSC at 50°C. The sections were then dehy- mounted and examined with a photomicroscope equipped with
drated in a graded series of ethanol, air dried, coated with NTB2 dark-field illumination.
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H19 gene COL2A1 Mesoderm-specific cDNA
(Clone #4) (Clone #5) Clone #6 (Clone #7) 3-actin
28S 28S
Fig. 4. Northern blot analyses of differentially expressed clones in various developmental stages of mouse kidney. A total of 30 rg of total RNA were
denatured with glyoxal, subjected to 1% agarose gel electrophoresis, capillary transferred to nylon membranes, and hybridized with [o-32P1-dCTP
radiolabeled differentially expressed clones and j3-actin. Lanes 13d and 17d are total RNA from 13 day and 17 day embryonic mouse kidneys, and lanes
NB and 3W are newborn and three-week-old mice renal total RNA. H19 gene (Clone #4) and mesoderm-speciflc eDNA (Clone #7) are abundantly
expressed in 13-day embryonic kidney, and their mRNA expressions gradually declined during the embryonic and neonatal periods, and were
undetectable in 3-week-old mouse kidney. Transcripts of mouse COL2A1 and clone #6 were not detectable during various developmental stages of the
mouse kidney. The expression of 13-actin remains constant in different developmental stages of the kidney.
250
H19 gene COL2A1 Mesoderm-
(Clone #4) (Clone #5) Clone #6 specific cDNA
(Clone #7)
259 b.p. 198 b.p. 219 b.p. 363 b.p.
Results
First subtraction of RDA detected embryonic globin genes from
embryonic kidney
To identify the differentially expressed genes during metaneph-
nc development, cDNA-RDA was performed by using E13 and
P3 kidney cDNAs. Intially, by agarose gel electrophoretogram of
DP3, three distinct bands (clone #1, 331 bp; #2, 257 bp; #3, 183
bp) were identified (Fig. 2A). These products were gel-purified
and ligated into pBluescript and sequenced. Clone #1 and #3 had
identical nucleotide sequence match with mouse €-globin eDNA
(GenBank accession #M26897) [11], and clone #2 to mouse
-globin cDNA (GenBank accession #M26898) [11]. These genes
Fig. 5. Southern blot analyses of R-amplicons
with inserts of cloned difference products. DpnII-
digested R-amplicons of 13-day embryonic and
3-week-old mouse kidneys were subjected to
2% agarose gel electrophoresis, denatured in
1.5 M NaCI, 0.5 N NaOH, neutralized in 0.5 M
Tris-HCI (pH 7.4), 1.5 M NaCI, and transferred
to nylon membranes. Mouse H19 gene and
mesoderm-specific cDNA (Clones #4 and #7)
radiolabeled probes strongly hybridized with
13-day R-amplicon (13d) and not with 3-week-
old (3W) mouse kidney R-amplicon. Mouse
COL2A1 (Clone #5) is detected only in 13d
kidney R-amplicon. Clone #6 is detected in
both the 13 day and 3-week R-amplicons, and is
differentially expressed in 13-day embryonic
kidney. Hybridization with j3-actin probe shows
no differences in R-amplicons of 13-day and
3-week mice kidneys.
were originally identified by comparison of two-dimensional (2D)
gel electrophoretic profiles of [35S]-labeled proteins extracted
from embryos harvested at various stages of the gestation [ii],
and they were found to be expressed only in embryonic mice at
days 8 to 10 of the gestation.
Differentially expressed genes during metanephric development were
fiuther identified by the depletion of embryonic globin cDNAs
Conceivably, it is difficult to avoid the contamination of E13
mouse kidneys with fetal erythrocytes while dissecting the em-
bryos. These fetal erythrocytes have highly up-regulated expres-
sion of embryonic globin genes, and the latter would suppress the
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Fig. 6. Northern blot analyses of Clone # 6 in various organs of adult and embryonic mouse tissues. Total RNA was extracted from various adult (A) and
embryonic (B) tissues, subjected to 1% agarose gel electrophoresis, transferred to Nylon membranes, and hybridized with [a32P]-dCTP radiolabeled
clone #6 and 13-actin. Transcripts of the size of --10 Kb are barely detectable in adult brain and lung tissues. Among the various embryonic tissues, this
transcript is readily detectable in the lung of 13-day fetal mouse.
amplification of other genes during cDNA-RDA. Therefore,
attempts were made to deplete out the globin genes during
cDNA-RDA. Plasmid DNAs of clones #1, #2, and #3 were
digested with DpnII. About 2 p.g of digested plasmid DNA, from
each clone, was added to the driver (40 jig):tester (0.4 jig)
mixture. The entire process of cDNA-RDA was repeated by the
"plasmid DNA supplementation" of the hybridization mixtures.
With the plasmid supplementation, embryonic globin genes de-
pleted-DP3 revealed a single distinct band by 2% agarose gel
electrophoresis (Clone #4, 259 bp; Fig. 2B). Sequence analysis of
clone #4 indicated that it is a DpnII fragment of mouse H19 gene
(GenBank accession #X58196) [121. To further isolate differen-
tially expressed genes, embryonic glohin genes depleted-DP3,
apparently containing minor population of cDNAs, was digested
with DpnII and randomly ligated into BamHI-digested pBlue-
script KS(+). Transformed colonies were randomly picked, plas-
mid DNAs isolated, and sequenced. In addition to H19 gene,
another three cDNA clones were obtained. Two clones were
known genes, that is, mouse al(II) collagen gene (COL2A1,
GenBank accession #M63708) [131 (clone #5), and mouse novel
mesoderm-specific gene (GenBank accession #D16262) [141
(clone #7). Clone #6 did not show significant homology to non-
redundant GenBank+EMBL+DDBJ sequences (except EST, STS
sequences) by the BLAST search. However, the BlAST search
through EST division of the non-redundant GenBank+EMBL+
DDBJ revealed that clone #6 has 84% homology with "yp84dlO.sl
Homo sapiens cDNA clone 194131 3' similar to SP:S37671, S37671
BAT2 protein" (GenBank accession #H51043; Fig. 3A). In addition,
the BLASTX search through the non-redundant GenBank CDS
translations+PDB+SwissProt+PIR indicated that translation of
clone #6 (frame + 1) showed 70.8% identity with human HLA-B-
associated transcript 2 (BAT2) (GenBank accession #M33509),
although these clones did not show any significant homology with
each other at the nucleotide level (Fig. 3B). The details of identified
clones are summarized in Table 1.
Northern and Southern blot analyses of differentially expressed
genes
To confirm up-regulated expression of the identified genes,
Northern blot analyses were performed. Clone #4 (H19 gene,
—2.5 Kb) and clone #7 (mesoderm-specific eDNA, —-3.0 Kb)
showed abundant expression in E13 kidney, and their expression
gradually decreased during the E17 and neonatal kidneys, and
mRNA transcripts were undetectable in P3 mouse kidney (Fig. 4).
Northern blot analyses of clone #5 (al type II collagen) and clone
#6 revealed undetectable expression in all the developmental
stages of the mouse kidney. Southern blot analyses of PCR
amplified R-amplicons were also performed to further study the
differential expression of the isolated clones. Clones #4 and #7
were highly expressed in E13 kidney R-amplicon, and were
undetectable in P3 kidney R-amplicon (Fig. 5). The expression of
clone #5 (COL2AI) was detected in El 3 kidney only, as indicated
by a faint band. Its expression was undetectable in P3 kidney. The
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level of expression was observed in the glomeruli, and it seemed
to be confined to the mesangial cells. A negligible message was
observed in the tubules, and it was comparable to that seen in the
control sections hybridized with sense riboprobe (not shown).
Discussion
Fig. 7. Dark-field light microscopic autoradiograms of in situ hybridization
for mesoderm-specific cDNA (clone #7,). The tissue Sections from E13 (A)
and P3 (B) mouse kidneys were hybridized with [o-33P]dUTP-labeled
antisense riboprobe, synthesized from mesoderm-specific cDNA. In E13
kidney, a high level of expression for mesoderm-specific cDNA is observed
in the metanephric mesenchyme (M), while minimal or no message is seen
in the ureteric bud branches (U). In P3 kidney, a low level of expression,
mostly confined to mesangium of the glomeruli (G), is observed. Abbre-
viation T is tubules. (Magnification )< 100) Publication of this figure in
color was made possible by the Nephrology Research Funds from the
Northwestern Memorial Hospital/University, Chicago, Illinois, USA.
expression of clone #6 was observed in both E13 and P3 mouse
kidney R-amplicons, and was up-regulated in the E13 kidney (Fig.
5). Lastly, the expression of clone #6 was investigated in various
adult and embryonic mouse tissues. Northern blot, containing
RNA from various tissues, was hybridized with [a32P]dCTP-
labeled clone #6. A faint —10 Kb transcript was observed in adult
mouse brain and lung after extended autoradiographic exposure
(Fig. 6A). Nevertheless, a distinct —10 Kb transcript was observed
in E13 lung (Fig. 6B), indicating its differential regulation during
embryonic life.
Expression of mesodemz-specific eDNA
In E13 kidney (Fig. 7A), a very high level of expression for
mesoderm-specific eDNA was observed in the metanephric mes-
enchyme, while minimal or no message was observed in the
ureteric bud branches and epithelial components of the nascent
nephrons, suggesting a high degree of specificity for the meso-
derm-specific eDNA expression. In P3 kidney (Fig. 7B), a very low
Differential display PCR (DD-PCR) has overcome various
problems encountered in subtractive hybridization techniques
described in the early 1980s. In DD-PCR, only minute amounts of
mRNA (< I j.Lg) are required, and it is relatively less time
consuming [41. During the last two to three years, using DD-PCR,
several differentially expressed genes have been identified in
various pathobiological states, including neoplasia [15], hypergly-
cemia [16], hypoxia [17], obesity [18, 19], transplant rejection [20],
gene-activation by growth factors [21, 22] and oncogenes [23, 24].
In spite of these interesting results, DD-PCR presents some
intractable technical problems, such as the isolation of false
positive clones, which do not exihibit differential expression by
Northern blot analysis. Even with further improvements in DD-
PCR procedure, which included modification of the random
primers [25—29], use of non-denaturing sequencing gels [25],
employment of automated fluorescent DNA sequencer [301, use
of Taq DNA polymerase from different sources [27], selection of
clones by dot blot method [31], and choice of Eppendorf tubes
[32], the problems relating to inadvertent isolation of false clones
persisted. In contrast, in cDNA-RDA, the use of specific 24-mer
and amplification of only difference or subtracted products dra-
matically minimizes the isolation of false positive clones, com-
pared to DD-PCR. Secondly, by cDNA-RDA, distinct bands of
difference products are easily visualized by agarose gel electro-
phoresis, and the ones which are not visualized can be randomly
ligated into plasmid vector and isolated. Thirdly, hybridization
and amplification processes can be readily modified by changing
the tester:driver ratio. Fourthly, unwanted clones can be elimi-
nated by supplementaion of plasmid DNA into the driver.
To isolate the up-regulated genes in embryonic kidneys, eDNA-
RDA was employed, in our initial attempts, the Third difference
product (DP3) revealed three distinct electrophoretic bands, and
they were identified as embryonic globin genes. It is interesting to
note that previous protein expression analysis of mouse embryos,
harvested at 8 to 10 days of gestation, by 2-D gel electrophoresis,
also detected the differential up-regulation of these globin genes
[11]. Since they are the classic prototype of developmentally
regulated genes, the cDNA-RDA technique to explore the expres-
sion of embryonic genes is quite useful. Moreover, supplementa-
tion of the isolated genes into the driver during cDNA-RDA
further enhances the sensitivity of this techniques to detect
developmentally regulated gene, including the rare transcripts. By
supplementation of embryonic globin genes into the driver (P3
kidney eDNA), we isolated four additional cDNAs (H19 gene,
COL2AI gene, mesoderm-specific cDNA, and unknown clone
#6), which were differentially expressed in E13 kidney. The H19
gene was originally identified as an abundant hepatic fetal-specific
mRNA [12], and it is expressed at the blastocyst stage of the
development, and accumulates with high levels in tissues of
endodermal and mesodermal origin, including the embryonic
kidney. The functions of the H19 gene are unknown. It is an
imprinted gene, which is expressed exclusively from the maternal
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chromosome [33]. It is not associated with ribosomes, but impor-
tantly enough, it has an anti-tumor effect [34]. Novel mesoderm-
specific cDNA was originally isolated by differential screening of
an embryonal carcinoma (EC) cell line MC12 cDNA library [14].
Although, mRNA of mesoderm-specific cDNA was detected in
tissues of mesodermal origin, the function of its protein product is
unknown. One may speculate about the relevance of mesoderm-
specific gene in murine metanephric development, since it was
found heavily expressed in metanephric mesenchyme of E13
kidney and its expression was barely detectable in P3 kidney.
In contrast to H19 gene and mesoderm-specific eDNA, the
other two clones, that is, COL2A1 and novel clone #6, were rare
transcripts expressed in E13 kidney of mouse, as ascertained by
Northern blot analysis. Nevertheless, they were differentially
expressed, as indicated by the Southern blot analysis of R-
amplicons of E13 and P3 mouse kidneys. Expression of COL2A1
has been described to be restricted to the cartilage [35]; however,
its expression in non-cartilaginous tissues, including brain, eye,
cochlea, heart, and epidermis, during embryonic development has
also been reported [36, 37]. In line with these observations are the
results of this investigation that indicate that the COL2AI gene is
also expressed in the embryonic metanephros, and it is de-
velopmentally regulated. Clone #6 did not have nucleotide se-
quence homology to any other known genes, reported in the
GenBank+EMBL+DDBJ sequences. However, a BLAST search
through the EST (expression sequence tag) division indicated that
it has homology to an uncharacterized clone yp84dlO.sl human
EST, whose translated product has similarity to BAT-2 (BAT,
HLA-B-associated transcripts). The human MHC is a 3500 Kb
chromosomal segment, which is comprised of class I and II gene
families localized to distinct 1600 and 900 Kb regions, flanking a
central 1000 Kb region of MHC class III genes. The class III gene
family is made up of 19 genes, including newly identified BAT1-9
[38, 39]. Although similar genes homolgous to class III family have
been found in H-2S/H-2D interval of mouse chromosome 17, the
functions of BAT proteins are largely unknown [40]. Whether the
unknown clone #6 is related to BAT proteins remains to be
determined. The preliminary observations made by Northern blot
analysis reveal its transcript size to be —10 Kb, and it is develop-
mentally regulated in other embryonic tissues besides kidney, such
as E13 lung.
In summary, cDNA-RDA can detect not only the differentially
regulated genes with abundant mRNA transcripts, such as that of
globin genes, H19 gene and mesoderm-specific cDNA, but also
genes with rare transcripts like COL2A1 and unknown clone #6,
expressed during embryonic development. Besides in embryogen-
esis/organogenesis, the cDNA-RDA can be successfully employed
to study the differential regulation and isolation of known and
unknown genes during various disease processes. For instance, in
the streptozotocin-induced diabetic mouse kidneys, nine genes
had two- to fivefold up-regulated expression, and half of them
were novel genes (manuscript in preparation). These observations
emphasize the importance of cDNA-RDA in its application to
study the gene regulation in various renal pathobiological states.
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